May 31, 2013

United States of America ex rel. Steven M. Camburn et al. v. Novartis Pharmaceuticals Corporation

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 18, 2023

    Novartis Airs Mea Culpa As 2nd Circ. Probes Kickback Theory

    After a series of startling kickback cases, Novartis Pharmaceuticals on Wednesday contrasted its past misdeeds with newer accusations it bribed prescribers, and Second Circuit judges seemed sympathetic as they pressured a whistleblower's lawyer to substantiate a supposed nationwide scheme.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login